HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PTCT
PTC Therapeutics Inc
Healthcare Biotechnology · New Jersey, USA · Reports in usd
Market Cap: $5.69B
Market Cap
$5.69B
Enterprise Val
$4.14B
P/E Ratio
8.33
P/B Ratio
-27.71
Trailing PEG (1Y)
0.07
As Of
Apr 21, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$205.3M
Gross Margin95.78%
Profit Margin95.78%
Return on Equity-362.44%
Return on Assets25.21%
Current Ratio2.35
Debt/Equity-1.94
LT Debt/Equity-0.47
Revenue Per Share2.05

Income Statement

Dec 31, 2025
Revenue$164.7M
Cost of Revenue$7.0M
Gross Profit$157.7M
R&D$133.1M
SG&A$96.9M
Operating Expenses$229.1M
Operating Income-$71.3M
Interest Expense$55.2M
Tax Expense-$4.1M
Net Income-$135.0M
EPS (Basic)$-1.82
EPS (Diluted)$-1.67
EBIT-$83.9M
EBITDA-$69.2M
Consolidated Income-$135.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$984.6M
Accounts Receivable$181.6M
Inventory$79.6M
Current Assets$2.27B
LT Investments$0.00
Property, Plant & Equipment$135.4M
Intangibles$471.1M
Non-Current Assets$624.8M
Total Assets$2.90B
Accounts Payable$381.3M
Current Debt$302.1M
Current Liabilities$968.4M
LT Debt$96.6M
Non-Current Liabilities$2.14B
Total Liabilities$3.10B
Total Debt$398.7M
Retained Earnings-$2.96B
Shareholder Equity-$205.3M
Shares Outstanding80,288,305

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$34.3M
Investing Cash Flow$34.0M
Financing Cash Flow$302.5M
CapEx-$2.4M
Free Cash Flow-$36.6M
Depreciation & Amort.$14.7M
Stock-Based Comp$18.5M
Acquisitions / Disposals-$22.5M
Investment Activity$58.9M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$62.5M
Dividends Paid$0.00
Net Change in Cash$312.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h